Challenge
A top pharmaceutical company faced a serious market challenge: a rare cardiology condition was being significantly underdiagnosed, often misattributed to comorbid symptoms in older patients. Their goal was to increase awareness and prompt more patients to seek diagnosis and treatment—while navigating two new competitive product launches.
Key hurdles included: